Partnership Network
Mapping the strategic alliances, collaborations, and partnerships driving innovation across the human simulation technology ecosystem
150+
Active Partnerships
25
Top 25 Pharma Engaged
$8.5B+
Partnership Value
40+
Research Consortia
Major Pharmaceutical Partnerships
| Technology Company | Pharma Partner | Focus Area | Type | Value | Year |
|---|---|---|---|---|---|
| Recursion | Roche/Genentech | Oncology & Neuroscience | Strategic | $150M+ | 2024 |
| Recursion | Bayer | Oncology Drug Discovery | Strategic | $120M | 2023 |
| Insilico Medicine | Sanofi | AI Drug Discovery | Strategic | $1.2B | 2022 |
| Emulate | Roche | Organ-on-Chip ADME | Research | $50M+ | 2021 |
| Emulate | Johnson & Johnson | Liver & Intestine Models | Commercial | Undisclosed | 2020 |
| CN Bio | AstraZeneca | Multi-Organ Systems | Research | Undisclosed | 2022 |
| TissUse | Merck KGaA | Human-on-Chip Platform | Strategic | $25M | 2021 |
| HUB Organoids | Boehringer Ingelheim | Cystic Fibrosis Research | Research | Undisclosed | 2023 |
| Exscientia | Bristol Myers Squibb | AI Drug Design | Strategic | $1.2B | 2022 |
| Isomorphic Labs | Eli Lilly | AI Drug Discovery | Strategic | $45M+ | 2024 |
| Isomorphic Labs | Novartis | Small Molecule Design | Strategic | $37.5M | 2024 |
| Schrödinger | Novartis | Computational Drug Discovery | Commercial | Multi-year | 2020 |
Organ-on-Chip Technology Partnerships
EMU
+
FDA
Emulate & FDA CRADA
Cooperative Research and Development Agreement to evaluate Liver-Chip for drug-induced liver injury prediction and regulatory qualification.
CNB
+
MRC
CN Bio & UK MRC Centre
Collaboration with Medical Research Council for advancing multi-organ microphysiological systems in toxicology studies.
MIM
+
TNO
MIMETAS & TNO Netherlands
Strategic collaboration on gut-on-chip applications for microbiome research and inflammatory disease modeling.
HES
+
NCATS
Hesperos & NIH NCATS
Development of multi-organ human-on-chip systems for rare disease research under the Tissue Chip program.
AI Drug Discovery Collaborations
REC
+
NVIDIA
Recursion & NVIDIA BioNeMo
Partnership leveraging NVIDIA's BioNeMo platform and DGX Cloud to accelerate AI model training for drug discovery at unprecedented scale.
INS
+
TENCENT
Insilico Medicine & Tencent AI Lab
Strategic investment and AI collaboration combining Tencent's computing resources with Insilico's drug discovery algorithms.
QRS
+
GSK
Quris AI & GSK
Evaluation partnership using Quris Bio-AI platform combining patient-on-chip with AI for preclinical toxicity prediction.
TEMP
+
AMGEN
Tempus AI & Amgen
Multi-year collaboration leveraging Tempus's clinical data platform and AI for oncology drug development programs.
Organoid & Bioprinting Alliances
HUB
+
EPIC
HUB Organoids & Epic Sciences
Partnership combining HUB's organoid biobank with Epic's single-cell analysis for personalized medicine applications in oncology.
ORG
+
UNITE
Organovo & United Therapeutics
Strategic partnership and subsequent acquisition bringing 3D bioprinting technology to transplantable organ manufacturing.
CELK
+
ASPECT
CELLINK & Aspect Biosystems
Technology exchange and commercial partnership advancing bioprinting applications in tissue engineering and drug discovery.
INS
+
SBIO
InSphero & StemBioSys
Combined InSphero's 3D microtissue platform with StemBioSys's stem cell-derived matrices for enhanced organoid generation.
Major Research Consortia
IQ MPS Affiliate
Industry consortium advancing microphysiological systems qualification and standardization across 20+ member companies.
Emulate
CN Bio
MIMETAS
Nortis
TissUse
+15 Pharma
NIH Tissue Chip Program
$140M+ NIH initiative developing human tissue chip systems for drug efficacy and safety testing.
Hesperos
Emulate
MIT
Harvard
Wake Forest
Innovative Medicines Initiative (IMI)
EU public-private partnership funding organ-on-chip and AI drug discovery projects worth €5B+.
TissUse
MIMETAS
InSphero
European Pharma
MELLODDY (Machine Learning Ledger)
Federated machine learning platform enabling 10 pharma companies to train AI models on pooled data without sharing.
Owkin
Novartis
J&J
AstraZeneca
+6 Pharma
NC3Rs (UK)
National Centre for Replacement, Refinement & Reduction of Animals advancing NAM adoption in UK research.
CN Bio
Kirkstall
UK Pharma
Academic Partners
German Organ-on-Chip Society
National initiative coordinating organ-on-chip research across German academic and industry partners.
TissUse
Fraunhofer
Charité
German Universities
Notable M&A Activity
Acquisition
Recursion acquires Cyclica & Valence
$85M+ combined acquisition of AI drug discovery platforms expanding Recursion's computational chemistry and proteomics capabilities.
Acquisition
BICO acquires CELLINK portfolio
Swedish bioprinting conglomerate consolidating multiple bioprinting and bioconvergence companies under unified platform.
Acquisition
Tempus acquires Ambry Genetics
$600M acquisition adding genetic testing capabilities to Tempus's AI-powered precision medicine platform.
Acquisition
Crown Bioscience & JSR Life Sciences
Japanese materials company JSR acquires Crown Bioscience, integrating preclinical CRO services with materials expertise.
Navigate the Partnership Ecosystem
Explore detailed company profiles, technology comparisons, and investment analysis across the human simulation industry.